Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India (1) 'Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg' and (2) 'Zydus receives final approval from the USFDA for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg'